Phase 3 Trial Demonstrates Superior Patient Treatment Convenience of MC2-01 Calcipotriene Plus Betamethasone Dipropionate Cream Compared to Current Topical Suspension. J of Skin. 2020;4(5):s62. doi:10.25251/skin.4.supp.61